Investing Profile

Philip Scheltens

VCInvestor
Partner and Head of Dementia Fund at EQT Life Sciences
eqtgroup.com/about/people/phi...Amsterdam, Netherlands
Photo of Philip Scheltens, Partner at EQT Life Sciences
Your Intro Paths to Philip Scheltens

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Philip Scheltens on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
3
Current Fund Size
€260M

Philip Scheltens is on these Sector & Stage Rankings

Philip Scheltens's Investments On Record (3)

CompanyStageDateRound SizeTotal Raised
Asceneuron
Series CJul 2024$100M
$130M
Co-investors: Hakan Goker (M Ventures (Merck)), Henrijette Richter (Soffinova Partners)
QurAlis
Series BMar 2023$88M
$140M
Co-investors: Amy Schulman (Polaris Partners), Jeffrey Moore (MP Healthcare Venture Management), Johannes Fruehauf (Mission BioCapital), Cillian King (EQT Life Sciences), Roel Bulthuis (INKEF Capital), Laia Crespo (Sanofi Ventures), Stephen Thompson (Brandon Capital Partners)
Nobi
Series UnknownJan 2022$14M
$14M
Co-investors: Rudy Dekeyser (EQT Life Sciences)